ELFN1-AS1

Across TCGA pan-cancer cohorts, ELFN1-AS1 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated ELFN1-AS1 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher ELFN1-AS1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated ELFN1-AS1 expression acts as an unfavorable survival marker, although some lineages such as READ and BLCA show a favorable association.

KIRC, UVM, and COAD are the cancer types where ELFN1-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Median	All	0.556	0.688	<.001	152	view →
UVM	DFS	Median	All	0.557	0.929	<.001	121	view →
COAD	OS	Median	All	0.736	0.864	<.001	96	view →
KIRP	OS	Tertile	All	0.404	0.843	<.001	90	view →
ACC	DFS	Quartile	All	0.239	0.554	.003	70	view →
PAAD	DFS	Median	All	0.379	0.628	.001	58	view →
MESO	DFS	Tertile	All	0.277	0.516	.002	56	view →
UCEC	DFS	Median	All	0.862	0.931	<.001	36	view →
ESCA	OS	Quartile	II,III,IV	0.440	0.684	.009	31	view →
LAML	DFS	Tertile	All	0.419	0.704	.001	30	view →
READ	OS	Quartile	III,IV	0.795	0.290	.008	30	view →
BLCA	DFS	Quartile	III,IV	0.647	0.461	.008	26	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

ELFN1-AS1–KIRC (DFS)

Open the KIRC breakdown →